-
Published 7/28/2026
Sepulveda GP, Nawalaniec K, Nikorich I, Guschanskaia ES, Mora-Martin A, Esse R, Ceballos A, Xia C, Kwan J, Blum BC, Emili A, Cardamone MD, Perissi V, Costello CE, Grishok A. Proteolytic activation of c-MYC facilitated by DOT1L. Proc Natl Acad Sci U S A. 2026 Aug 04; 123(31):e2525603123. PMID: 42520114.
-
Published 7/24/2026
Mitra S, Burrone G, Rubarajan S, Klein C, Kwok T, Gutta S, Li KC, Berson E, Orofino J, Cardamone MD, Blower M, Perissi V. Spatial control of mitochondrial retrograde signaling by nuclear pore-associated contact sites. bioRxiv. 2026 Jul 24. PMID: 42539211.
-
Published 4/30/2025
Ferrero G, Cardamone MD, Luca F, Bourk E, Ricci L, Liu W, Gao Y, Burrone G, Muhammad A, Chan S, Smith E, Fan TC, Cutrupi S, Garcia-Bassets I, De Bortoli M, Rosenfeld MG, Perissi V. Nonproteolytic ubiquitination regulates chromatin occupancy by the NCoR/SMRT/HDAC3 corepressor complex in MCF-7 breast cancer cells. Proc Natl Acad Sci U S A. 2025 May 06; 122(18):e2502805122. PMID: 40305047.
-
Published 7/31/2024
Gao Y, Kwan J, Orofino J, Burrone G, Mitra S, Fan TY, English J, Hekman R, Emili A, Lyons SM, Cardamone MD, Perissi V. Inhibition of K63 ubiquitination by G-Protein pathway suppressor 2 (GPS2) regulates mitochondria-associated translation. Pharmacol Res. 2024 Sep; 207:107336. PMID: 39094987.
-
Published 2/9/2024
Mitro N, Verdeguer F, Perissi V. Editorial: Epigenetics and metabolism. Front Endocrinol (Lausanne). 2024; 15:1373368. PMID: 38405145.